Methyl Histamine/Crea.ratio

Sample type: Urine
Optimal result: 0 – 25 ug/mmol

The Methyl Histamine to Creatinine Ratio (Methyl Histamine/Crea. ratio) is a clinical biomarker used primarily to assess histamine metabolism and to indirectly gauge mast cell activity. Methyl histamine is a metabolite of histamine, a key inflammatory mediator involved in allergic reactions, immune responses, and physiological regulation, such as in gastric acid secretion and neurotransmission.

The Methyl Histamine to Creatinine Ratio (Methyl Histamine/Crea. ratio) is a clinical biomarker used primarily to assess histamine metabolism and to indirectly gauge mast cell activity. Methyl histamine is a metabolite of histamine, a key inflammatory mediator involved in allergic reactions, immune responses, and physiological regulation, such as in gastric acid secretion and neurotransmission.

Histamine is broken down by two enzymes: diamine oxidase (DAO) and histamine N-methyltransferase (HNMT). The latter converts histamine into methyl histamine. By measuring the level of methyl histamine in relation to creatinine in urine, clinicians can obtain a standardized metric to evaluate histamine production and clearance, considering the individual’s renal function. Creatinine normalization is important because it accounts for differences in urine concentration that can result from hydration levels or kidney efficiency.

This ratio is particularly useful in diagnosing and monitoring conditions characterized by abnormal histamine levels, such as mastocytosis or mast cell activation syndrome (MCAS). These are disorders where mast cells release excessive histamine into the body, leading to symptoms like flushing, itching, gastrointestinal issues, and anaphylaxis in severe cases. The methyl histamine/crea. ratio can help track disease progression or response to treatment.

Additionally, the ratio may be useful in understanding allergic diseases, asthma, and other inflammatory conditions where histamine plays a significant role. Elevated levels of methyl histamine may indicate overactive histamine release, while normal or low levels might suggest normal histamine metabolism.

In clinical settings, this biomarker serves as part of a broader diagnostic and monitoring strategy, especially in cases where direct histamine measurements in the blood or tissues may be more variable or less reliable. Its measurement is typically conducted through urine tests, offering a non-invasive approach for patient management.

Methyl Histamine/Crea.ratio
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Methyl Histamine/Crea.ratio — 10,000+ markers explained
One Methyl Histamine/Crea.ratio result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro